Science & technology | The search for a covid-19 treatment

Hydroxychloroquine is embroiled in yet more controversy

And so is the idea of peer review

ONCE PRAISED as a miracle cure for covid-19, an antimalarial drug called hydroxychloroquine has rarely been out of the headlines since the start of the pandemic. It was hoped it might find a new use as a therapy in patients who are unwell with the novel coronavirus. But in recent weeks a scientific picture has emerged of a treatment that does not appear to be helping patients at all, and might even be causing harm.

This article appeared in the Science & technology section of the print edition under the headline “Testing times”

The power of protest

From the June 13th 2020 edition

Discover stories from this section and more in the list of contents

Explore the edition

More from Science & technology

A person blowing about a pattern in the shape of a brain

Can you breathe stress away?

Scientists are only beginning to understand the links between the breath and the mind

The Economist’s science and technology internship

We invite applications for the 2025 Richard Casement internship


A man sits inside a pixelated pink brain while examining a clipboard, with colored squares falling from the brain

A better understanding of Huntington’s disease brings hope

Previous research seems to have misinterpreted what is going on


Is obesity a disease?

It wasn’t. But it is now

Volunteers with Down’s syndrome could help find Alzheimer’s drugs

Those with the syndrome have more of a protein implicated in dementia

Should you start lifting weights?

You’ll stay healthier for longer if you’re strong